(Press-News.org) April 2014, Perth, Australia. Drug discovery company Proteomics International has completed an important milestone towards the development of a companion diagnostic (CDx) test with the validation of several of its protein biomarkers.
The research team authenticated the panel of biomarkers after taking 508 highly curated disease and control samples. Seven biomarkers were validated at high stringency using the company's proprietary mass spectrometry approach.
The mass spectrometry data was then cross-validated using immunoassays in collaboration with the KTH Royal Institute of Technology, Sweden, and Merck Millipore. A further five biomarkers were validated at high stringency and these are available for out-licensing. The validation was supported by a grant from Commercialisation Australia.
Proteomics International managing director Richard Lipscombe said there was excellent correlation between the new mass spectrometry platform and the traditional gold standard test, essential because antibody assays are more readily accepted by the FDA. "By doing it as a diagnostic and showing that the whole approach works, we set the foundations to create tests for other medical conditions," Dr Lipscombe said.
The next stage of development is to create a test that can determine whether patients will get diabetic kidney disease before they develop the condition. "The Holy Grail is to predict who's going to get sick and who isn't and that's something that will come out of our study later in 2014." Dr Lipscombe said. "But in the short term we want a diagnostic test that is going to provide doctors with a more accurate, robust test."
The International Diabetes Foundation estimates that there are 382 million people living with diabetes and expect the number to rise significantly. Based on current statistics 10 to 15 per cent of all people with diabetes will die from kidney disease.
INFORMATION:
About Proteomics International
Proteomics International (established 2001) is privately owned with a sustainable business model that operates in three synergistic business units: Diagnostics, Therapeutics and Analytics (CRO). The Company has self-funded $5 million to develop a proven and proprietary protein biomarker discovery platform ("Biotarget") that could be used for other diseases. Proteomics International previously developed a drug discovery platform that identified several potential compounds from venom with success rates 100 times greater than the industry standard hit-rate for small molecule primary screens: http://www.proteomics.com.au
More information
Dr Roopwant Judge
Business Development
E roop@proteomics.com.au
Proteomics International biomarker study closer to a CDx test for diabetic kidney disease
Proteomics now seeks a commercialisation partner to enter the RUO, LDT or IVD markets
2014-04-14
ELSE PRESS RELEASES FROM THIS DATE:
Beneficial organisms react differently to parasite drug
2014-04-14
The substance ivermectin has been used for more than thirty years all over the world to combat parasites like roundworms, lice and mites in humans, livestock and pets. The active ingredient belongs to the chemical group of avermectins, which generally disrupt cell transport and thus attack pests. When ivermectin is excreted in the faeces of treated animals, at overly high doses it also harms dung-degrading beneficial insects like dung beetles and dung flies. This impairs the functioning of the ecosystem. In extreme cases the dung is not decomposed and the pasture is destroyed.
Sensitivity ...
Does germ plasm accelerate evolution?
2014-04-14
Scientists at The University of Nottingham have published research in the leading academic journal Science that challenges a long held belief about the way certain species of vertebrates evolved.
Dr Matt Loose and Dr Andrew Johnson who are experts in genetics and cell development in the School of Life Sciences carried out the research, funded by the Medical Research Council (MRC). It suggests that genes evolve more rapidly in species containing germ plasm. The results came about as they put to the test a novel theory that early developmental events dramatically alter ...
Novel technique developed by NUS scientists opens door to better solar cells
2014-04-14
A team of scientists, led by Assistant Professor Andrivo Rusydi from the Department of Physics at the National University of Singapore's (NUS) Faculty of Science, has successfully developed a technique to study the interface between materials, shedding light on the new properties that arise when two materials are put together.
With a better understanding of how materials interface, scientists can tweak the properties of different materials more easily, and this opens doors to the development of better solar cells, novel superconductors and smaller hard drives.
The ...
Stanford team develops single cell genomics technique to reverse engineer developing lung
2014-04-14
Consider the marvel of the embryo. It begins as a glob of identical cells that change shape and function as they multiply to become the cells of our lungs, muscles, nerves and all the other specialized tissues of the body.
Now, in a feat of reverse tissue engineering, Stanford researchers have begun to unravel the complex genetic coding that allows embryonic cells to proliferate and transform into all of the specialized cells that perform a myriad of different biological tasks.
A team of interdisciplinary researchers took lung cells from the embryos of mice, choosing ...
Saturn's hexagon: An amazing phenomenon
2014-04-14
In 1980 and 1981 NASA's Voyager 1 and 2 space probes passed for the first time over the planet Saturn, located 1,500 million km from the Sun. Among their numerous discoveries they observed a strange, hexagon-shaped structure in the planet's uppermost clouds surrounding its north pole. The hexagon remained virtually static, without moving, vis-à-vis the planet's overall rotation that was not accurately known. What is more, the images captured by the Voyager probes found that the clouds were moving rapidly inside the hexagon in an enclosed jet stream and were being dragged ...
Longer nurse tenure on hospital units leads to higher quality care
2014-04-14
(NEW YORK, NY, April 14, 2014) – When it comes to the cost and quality of hospital care, nurse tenure and teamwork matters. Patients get the best care when they are treated in units that are staffed by nurses who have extensive experience in their current job, according to a study from researchers at Columbia University School of Nursing and Columbia Business School. The study was published in the current issue of the American Economics Journal: Applied Economics.
The review of more than 900,000 patient admissions over four years at hospitals in the Veterans Administration ...
Chemotherapy before or after surgery for high-risk bladder cancer improves survival, but is not routinely administered
2014-04-14
Contrary to treatment guidelines for high-risk bladder cancer, chemotherapy before or after surgery is not commonly used in routine clinical practice. The findings are published early online in Cancer, a peer-reviewed journal of the American Cancer Society.
Clinical trials have shown that survival is improved in patients with muscle-invasive bladder cancer who are given chemotherapy before surgery. There is less evidence about whether chemotherapy after surgery also improves survival. To investigate the use of peri-operative chemotherapy in this disease, Christopher Booth, ...
Celebrity Hairstylist Fateemah Lends Her Talents to "I Am Everything" Benefit Fashion Show
2014-04-14
Award-winning style maven Faatemah has signed on as lead hairstylist for designer Emma Berg's "I Am Everything" benefit fashion event, Tuesday, April 22 at the Ritz Theater. Combining the worlds of fashion and philanthropy, the event will feature Berg's Spring/Summer 2014 collection of prom dresses inspired by 10 senior high school students selected from five Boys & Girls Clubs across the Twin Cities. The young women will walk the runway in the dresses designed exclusively for them.
Faatemah will provide hair styling services and direction, bringing her retro glam ...
Author and Poet Kneika Robbins Shares Her Writing Journey via the Dark Mantis Talk Show
2014-04-14
Kneika Robbins is a gifted motivational writer that enjoys the art of writing and sharing her poetry with the world. Kneika has been writing for 23 years. Kneika is now a motivational poetry columnist for Sibella Poetry Magazine and involved with the program "Poet a Day" at Johnson County Library. Kneika will also discuss her first novel titled "Serious Thoughts" with Jeanette Michelle.
Kneika Robbins is a wife and mother who are an Educator, Assessor and Mentor when she is not writing. Kneika earned her Bachelor's degree in Healthcare Administration and Associates ...
Second Annual "Uncork for Hope" Shines a Light on Boy's Town California's Mission to Change the Lives of At-Risk Children and Families
2014-04-14
Boys Town California board member Adam Miller, today announced that he will host the second annual "Uncork for Hope" charity wine tasting. The event will be held on Sunday, May 4, 2014 from 2-5 p.m. at the Center Club in Costa Mesa, Calif. All of the proceeds of the event will go to Boys Town California.
The title sponsors for this year's wine tasting event are First Team Estates and Christie's International Real Estate. As a special bonus, guests can opt to participate in a special wine seminar conducted by Margaux Pierog Kugelman, Advanced Sommelier of Treasury Wine ...
LAST 30 PRESS RELEASES:
Pandemic raised food, housing insecurity in Oregon despite surge in spending
OU College of Medicine professor earns prestigious pancreatology award
Sub-Saharan Africa leads global HIV decline: Progress made but UNAIDS 2030 goals hang in balance, new IHME study finds
Popular diabetes and obesity drugs also protect kidneys, study shows
Stevens INI receives funding to expand research on the neural underpinnings of bipolar disorder
Protecting nature can safeguard cities from floods
NCSA receives honors in 2024 HPCwire Readers’ and Editors’ Choice Awards
Warning: Don’t miss Thanksgiving dinner, it’s more meaningful than you think
Expanding HPV vaccination to all adults aged 27-45 years unlikely to be cost-effective or efficient for HPV-related cancer prevention
Trauma care and mental health interventions training help family physicians prepare for times of war
Adapted nominal group technique effectively builds consensus on health care priorities for older adults
Single-visit first-trimester care with point-of-care ultrasound cuts emergency visits by 81% for non-miscarrying patients
Study reveals impact of trauma on health care professionals in Israel following 2023 terror attack
Primary care settings face barriers to screening for early detection of cognitive impairment
November/December Annals of Family Medicine Tip Sheet
Antibiotics initiated for suspected community-acquired pneumonia even when chest radiography results are negative
COVID-19 stay-at-home order increased reporting of food, housing, and other health-related social needs in Oregon
UW-led research links wildfire smoke exposure with increased dementia risk
Most U.S. adults surveyed trust store-bought turkey is free of contaminants, despite research finding fecal bacteria in ground turkey
New therapy from UI Health offers FDA-approved treatment option for brittle type 1 diabetes
Alzheimer's: A new strategy to prevent neurodegeneration
A clue to what lies beneath the bland surfaces of Uranus and Neptune
Researchers uncover what makes large numbers of “squishy” grains start flowing
Scientists uncover new mechanism in bacterial DNA enzyme opening pathways for antibiotic development
New study reveals the explosive secret of the squirting cucumber
Vanderbilt authors find evidence that the hunger hormone leptin can direct neural development in a leptin receptor–independent manner
To design better water filters, MIT engineers look to manta rays
Self-assembling proteins can be used for higher performance, more sustainable skincare products
Cannabis, maybe, for attention problems
Building a better path to recovery for OUD
[Press-News.org] Proteomics International biomarker study closer to a CDx test for diabetic kidney diseaseProteomics now seeks a commercialisation partner to enter the RUO, LDT or IVD markets